Global professional services firm Alvarez & Marsal (A&M) appointed Roger Weems as a managing director in the firm’s healthcare industry group, within its health systems practice. Weems’ joining advances A&M healthcare industry group’s ability to support hospitals and health systems with large scale, operational and financial transformation.
With more than twenty-five years of experience, Weems has led academic medical centers and other health systems through large-scale enterprise transformations and strategic multi-year turnarounds. He works closely with health system executive teams and boards to drive change and uncover growth opportunities. Weems also has notable experience designing and executing large scale transformation plans for both academic medical centers and health systems. Specifically, he led a $200+ million financial turn-around for a financially distressed academic medical center which enabled the organization to grow into a multi-hospital system as well as designing a multi-year $400 million transformation for a large health system in the Southeast.
Having held consulting and health system organization leadership roles, Weems has the performance improvement, financial sustainability strategy and post-merger integration expertise required for advising on large-scale change initiatives that benefit providers and the communities they serve.
“As providers are increasingly facing pressures with margins, staffing issues and operational hurdles, Roger’s joining further enables us to guide health systems through large, enterprise-wide transformations and turnarounds,” Martin McGahan, managing director and co-head of A&M’s healthcare industry group, said.
“Roger joins our mission of delivering solutions, rooted in A&M’s operational heritage, with the strategic stretch to address issues looming on the horizon,” Chris George, managing director and health systems practice leader, said. “His proven track record and mindset align with our action-oriented approach, helping clients achieve transformative, long-term financial sustainability.”
Prior to joining A&M, Weems served as managing director and chief growth officer at Impact Advisors where he focused on health system transformation and growth strategies. Previously, he served as vice president and national market leader for Premier Inc. Earlier in his career, Weems founded a consulting business focused on labor optimization and patient throughput solutions which was acquired by Navigant Consulting.
Weems earned a bachelor’s degree from the University of Alabama and MBA and MHA degrees from the University of Colorado Denver.
A&M also appointed John Arp as a managing director within its corporate transactions group (CTG) as the practice crosses its first-year milestone. Based in Atlanta, Arp specializes in M&A strategy, operational due diligence and deal execution and boasts sought-after expertise in the agriculture inputs, industrial and chemical industries. In this new role, he further cements CTG’s operational and diligence capabilities, driving efficiency and delivering impactful results across key industry verticals.
Arp brings over 25 years of operations, commercial, corporate strategy and M&A experience in both industry and deal advisory consulting to his role. Arp has spent his career focused on the chemicals and agricultural industry verticals, most recently serving as the Head of KPMG’s U.S. chemicals and materials industry team. In this role, he helped build the practice from its infancy, focusing on full lifecycle deal advisement and execution for small to large multinational corporate clients. Prior to joining KPMG, Arp worked for BASF, the world’s largest chemical production company, where he served on the leadership team of a global business startup in the agriculture division and was responsible for strategy implementation and corporate development.
As CTG crosses its first-year anniversary as a practice, Arp’s appointment is emblematic of its continued strategy to invest in senior transaction leaders who deepen the firm’s sector expertise and operational prowess.
“When we launched CTG in the U.S. a year ago, our objective was simple: build a better solution for corporate clients,” managing director and global practice leader Paul Aversano, who heads the firm’s global transaction advisory group (global TAG) and maintains oversight of CTG, said. “Since then, the corporate transactions arena remains ripe with opportunity while growing in complexity amidst continued market uncertainty. The demand for a unique service provider like CTG, with A&M’s globally integrated platform at its foundation, grows with it. As we continue to scale CTG with strategic assertiveness, bringing aboard senior market leaders like John — who share our unwavering commitment to unlocking value for clients — is crucial to cementing our position as the preferred service alternative for corporate and strategic clients.”
“As CTG marks its one-year anniversary, John’s leadership adds the chemicals and industrial capabilities depth that clients are looking for,” Preston Parker, managing director and U.S. CTG practice leader, said. “His perspective on deals, ability to lead cross-functional teams and use of best practices supports the delivery of results that clients demand. Clients trust in A&M’s sector experience, operational know-how and M&A mastery to capitalize on opportunities with speed and precision. John’s joining extends our ability to do just that.”
“A&M’s entrepreneurial culture, ability to flex across strategy and execution and freedom from audit conflicts positions the firm as a market leader for corporate M&A,” Arp said. “Inconsistent M&A strategy, poor execution and cross-functional disconnects can greatly impact accretive value in transactions. CTG’s model is structured to close those gaps, mitigate risks and maximize value. A&M’s commitment to acting with urgency for making an impact aligns with my approach to supporting clients.”
